z-logo
Premium
IgG‐Antiphospholipid Antibodies in Follicular Fluid of IVF‐ET Patients are Related to Low Fertilization Rate of Their Oocytes
Author(s) -
Matsubayashi Hidehiko,
Sugi Toshitaka,
Arai Tadashi,
Shida Masako,
Kondo Akane,
Suzuki Takahiro,
Izumi Shunichiro,
McIntyre John A.
Publication year - 2006
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.1600-0897.2006.00374.x
Subject(s) - follicular fluid , in vitro fertilisation , infertility , embryo transfer , unexplained infertility , antibody , andrology , follicular phase , antiphospholipid syndrome , human fertilization , immunoglobulin g , medicine , immunology , biology , pregnancy , embryo , oocyte , genetics , anatomy
Problem Patients undergoing in vitro fertilization and embryo transfer (IVF‐ET) failures show an increased incidence of antiphospholipid antibodies (aPL) in their blood. The physiological manifestations of aPL in this patient group are nonetheless controversial. Pathological effects of aPL on embryos in vitro have been documented. We questioned whether aPL if found in follicular fluids (FFs) could result in embryonic damage. Method of study Blood from 44 patients with three or more IVF‐ET failures were tested by enzyme‐linked immunosorbent assays (ELISA) for the presence of immunoglobulin (Ig)G, IgM and IgA aPL. Both the 29 aPL‐positive and 15 aPL‐negative patients gave permission for FF collection during their next IVF‐ET attempt for additional aPL determinations. Results Patients with no aPL in their blood, had no aPL in their FFs. Patients with IgG and/or IgM aPL in their blood had IgG but not IgM in their respective FFs. Conclusions The presence of IgG aPL in FFs and increased infertility length were significantly related to lower fertilization rates, independently. Follicular fluid IgG aPL appears as a risk factor in association with successful IVF‐ET outcomes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here